AgeX Therapeutics, Inc.

AGE

...

AGE: AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develops medicines designed to address some of the unsolved problems in aging. Its PureStem-derived cell-based therapeutic candidates in development are AGEX-VASC1, AGEX-BAT1 and AGEX-iTR1547.

Show AGE Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of AGE by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by AGE's directors and management

No recent Insider Trading for this ticker

Insider Trading Dashboard

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on AGE's company Twitter account

WallStreetBets

Number of mentions of AGE in WallStreetBets Daily Discussion

AGE News

Recent insights relating to AGE

CNBC Recommendations

Recent picks made for AGE stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in AGE

Corporate Flights

Flights by private jets registered to AGE